Ed Verbeek schreef op 4 oktober 2021 14:55:
[...]
Lijkt me erg onverstandig gezien de
grotere kans op (ernstige) bijwerkingen van inenting van mensen die al een infectie doormaakten:
"Given preliminary evidence from small studies21, 22, 23 suggesting that reactogenicity is higher among individuals previously infected with SARS-CoV-2, we investigated the extent to which previous SARS-CoV-2 infection (based on self-reported previous positive PCR or lateral flow result) was associated with reports of adverse effects. Individuals vaccinated with a single dose of BNT162b2 were more likely to report systemic effects if they had a previous SARS-CoV-2 positive test than were those without known past infection (5148 [35·8%] of 14?369 vs 33?007 [12·3%] of 267?734; OR 3·97 [95% CI 3·83–4·12], p<0·0001). A similar effect was seen for ChAdOx1 nCoV-19 first dose inoculation (7551 [53·1%] of 14?231 with past infection vs 108?922 [32·9%] of 331?049 without past infection; 2·31 [2·23–2·38], p<0·0001; figure 3) and BNT162b2 second dose inoculation (859 [38·2%] of 2251 vs 5357 [20·6%] of 25?956; 2·37 [2·17–2·60], p<0·0001)."
www.sciencedirect.com/science/article...Dr Campbell: "56% more likely to experience a severe slide effect that required hospital care"